Bone Biologics(us:BBLG)

    0.9919

    -1.79%

    Updated on 2024-12-23

    Open:1.01
    Close:0.9919
    High:1.01
    Low:0.9208
    Pre Close:1.01
    Volume:320603.00
    Amount:308995.06
    Turnover:13.01%
    Shares:2.46M
    MarketCap:2.44M

    About

    Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
    Address:2 Burlington Woods Drive,Suite 100

    Market Movers